Literature DB >> 25000980

Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.

Tzu-Sheng Hsu1, Huey-Wen Hsiao2, Pei-Jung Wu3, Wen-Hsien Liu2, Ming-Zong Lai4.   

Abstract

The generation of T cell anergy is associated with upregulation of ubiquitin E3 ligases including Casitas B-lineage lymphoma (Cbl-b), Itch, gene related to anergy in lymphocyte, and deltex1 (DTX1). These E3 ligases attenuate T cell activation by targeting to signaling molecules. For example, Cbl-b and Itch promote the degradation of protein kinase Cθ (PKCθ) and phospholipase C-γ1 (PLC-γ1) in anergic Th1 cells. How these anergy-associated E3 ligases coordinate during T cell anergy remains largely unknown. In the current study, we found that PKCθ and PLC-γ1 are also downregulated by DTX1. DTX1 interacted with PKCθ and PLC-γ1 and stimulated the degradation of PKCθ and PLC-γ1. T cell anergy-induced proteolysis of PKCθ was prevented in Dtx1(-/-) T cells, supporting the essential role of DTX1 in PKCθ downregulation. Similar to Cbl-b and Itch, DTX1 promoted monoubiquitination of PKCθ. Proteasome inhibitor did not inhibit DTX1-directed PKCθ degradation, but instead DTX1 directed the relocalization of PKCθ into the lysosomal pathway. In addition, DTX1 interacted with Cbl-b and increased the protein levels of Cbl-b. We further demonstrated the possibility that, through the downregulation of PKCθ, DTX1 prevented PKCθ-induced Cbl-b degradation and increased Cbl-b protein stability. Our results suggest the coordination between E3 ligases during T cell anergy; DTX1 acts with Cbl-b to assure a more extensive silencing of PKCθ, whereas DTX1-mediated PKCθ degradation further stabilizes Cbl-b.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25000980     DOI: 10.4049/jimmunol.1301416

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma.

Authors:  Leo Meriranta; Annika Pasanen; Riku Louhimo; Alejandra Cervera; Amjad Alkodsi; Matias Autio; Minna Taskinen; Ville Rantanen; Marja-Liisa Karjalainen-Lindsberg; Harald Holte; Jan Delabie; Rainer Lehtonen; Sampsa Hautaniemi; Sirpa Leppä
Journal:  Haematologica       Date:  2017-02-09       Impact factor: 9.941

Review 2.  E3 ubiquitin ligases in B-cell malignancies.

Authors:  Jaewoo Choi; Luca Busino
Journal:  Cell Immunol       Date:  2019-02-26       Impact factor: 4.868

3.  The associations between Deltex1 and clinical characteristics of breast cancer.

Authors:  Xiaoyi Liu; Yuwei Xian; Hongmei Xu; Meixiang Hu; Kui Che; Xiangping Liu; Haibo Wang
Journal:  Gland Surg       Date:  2021-11

Review 4.  Ubiquitin signaling in immune responses.

Authors:  Hongbo Hu; Shao-Cong Sun
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

Review 5.  Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development.

Authors:  Jeong-Ryul Hwang; Yeongseon Byeon; Donghwan Kim; Sung-Gyoo Park
Journal:  Exp Mol Med       Date:  2020-05-21       Impact factor: 8.718

Review 6.  The Role of PKC-θ in CD4+ T Cells and HIV Infection: To the Nucleus and Back Again.

Authors:  Chansavath Phetsouphanh; Anthony D Kelleher
Journal:  Front Immunol       Date:  2015-07-30       Impact factor: 7.561

7.  c-FLIP is a target of the E3 ligase deltex1 in gastric cancer.

Authors:  Tzu-Sheng Hsu; Shu-Ting Mo; Ping-Ning Hsu; Ming-Zong Lai
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

8.  Isoflurane decreases interleukin-2 production by increasing c-Cbl and Cbl-b expression in rat peripheral blood mononuclear cells.

Authors:  Ji Won Choi; Byung Seop Shin
Journal:  J Int Med Res       Date:  2018-06-24       Impact factor: 1.671

Review 9.  Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity.

Authors:  Poojitha Sitaram; Bradley Uyemura; Subramaniam Malarkannan; Matthew J Riese
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.